Text and picture: Luc Durel

Research and innovations accumulated over decades have advanced the dairy industry with better quality milk and a generally satisfactory sanitary situation as results. However, the treatment of intramammary infections has stayed in the background, with the traditional option of undiscriminating treatment. Recently, the European 2019/6 regulation on pharmaceutical products, particularly antibiotics, has thrown a severe challenge in the face of veterinarians and dairy producers.